The efficacy of integrative anti-depressive therapy on motor recovery after ischemic stroke – A randomized clinical trial

European Journal of Integrative Medicine

Volumn 35, Issue , 2020, Pages

  Gong, Li ^a   Yang, Xuejun ^a   Feng, Yu ^a   Fei, Zhimin ^a   Wang, Mingzhe ^a   Qin, Baofeng ^a   Wang, Qiudong ^b   Pan, Weidong ^a  

^a SHUGUANG HOSPITAL AFFILIATED TO SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Pudong New District Hospital of Traditional Chinese Medicine   (China)

Author keywords

Acanthopanax senticosus; Anti depressive therapy; Fluoxetine; Hypericum perforatum L; Integrative therapy; Ischemic stroke; Motor recovery; Randomized control trial; Shu Gan Jie Yu capsule

Indexed keywords

ANTIDEPRESSANT AGENT; CHINESE MEDICINAL FORMULA; FLUOXETINE; PLACEBO; SHU GAN JIE YU CAPSULE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHINESE MEDICINE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CONVALESCENCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; FUGL MEYER MOTOR SCALE; HERBAL MEDICINE; HUMAN; INTEGRATIVE MEDICINE; LOCOMOTION; MAJOR CLINICAL STUDY; MOTOR ACTIVITY; MOTOR DYSFUNCTION; MOTOR DYSFUNCTION ASSESSMENT; MOTOR PERFORMANCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; STROKE PATIENT; TREATMENT DURATION; WESTERN MEDICINE;

EID: 85082503704     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2020.101102     Document Type: Article

References (33)

1. Benjamin, E.J., Muntner, P., Alonso, A., Bittencourt, M.S., American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation 139:10 (2019), e56–e528.
2. Wu, S., Wu, B., Liu, M., Chen, Z., et al. China stroke study collaboration. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 18:4 (2019), 394–405.
3. Yan, Y., Wang, M., Zhang, L., Qiu, Z., et al. Nao-Xue-Shu oral liquid improves aphasia of mixed stroke. Evid. Complement. Altern. Med., 2015, 2015, 709568, 10.1155/2015/709568.
4. Cramer, S.C., Listening to fluoxetine: a hot message from the FLAME trial of poststroke motor recovery. Int. J. Stroke 6:4 (2011), 315–316.
5. Siepmann, T., Penzlin, A.I., Kepplinger, J., Illigens, B.M., et al. Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav., 5(10), 2015, e00373, 10.1002/brb3.373.
6. Marquez-Romero, J.M., Arauz, A., Ruiz-Sandoval, J.L., Cruz-Estrada Ede, L., et al. Fluoxetine for motor recovery after acute intracerebral hemorrhage (FMRICH):study protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials, 14, 2013, 77.
7. Jun, T., Weidong, P., Enhancing the ability of diagnosis and treatment of neuropsychiatric diseases in department of neurology in general hospitals. J. Neurol. Neurorehabil. 14:2 (2018), 62–66.
8. Wang, J., Guo, Y., Li, G.L., Current status of standardization of traditional Chinese medicine in China. Evid. Complement. Alternat. Med., 2016, 2016, 9123103, 10.1155/2016/9123103.
9. Huang, N., Rizshsky, L., Hauck, C., Nikolau, B.J., Identification of anti-inflammatory constituents in Hypericum perforatum and Hypericum gentianoides extracts using RAW 264.7 mouse macrophages. Phytochemistry 72:16 (2011), 2015–2023.
10. Hammer, K.D., Birt, D.F., Evidence for contributions of interactions of constituents to the anti-inflammatory activity of Hypericum perforatum. Crit. Rev. Food Sci. Nutr. 54:6 (2014), 781–789.
11. Feng, Yi, Jie, Li, Jikai, Rong, Guofu, Zhang, et al. Shuganjieyu capsule alone or in combination with other antidepressants for post-stroke depression: a meta-analysis. Chin. J. Cerebrovasc Dis. 15:3 (2018), 140–147.
12. Li, F., Harmer, P., Fitzgerald, K., Eckstrom, E., et al. Tai chi and postural stability in patients with Parkinson's disease. N. Engl. J. Med. 366:6 (2012), 511–519.
13. Ni, J., Li, X., Liu, M., Zhu, H., et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack (2014 AHA/ASA edition). Chin. J. Clin. Neurosci. 23:1 (2015), 65–73.
14. See, J., Dodakian, L., Chou, C., Chan, V., A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials. Neurorehabil. Neural Repair 27:8 (2013), 732–741.
15. Huybrechts, K.F., Caro, J.J., Xenakis, J.J., Vemmos, K.N., The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc. Dis. 26:4 (2008), 381–387.
16. Pariente, J., Loubinoux, I., Carel, C., Albucher, J.F., et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann. Neurol. 50:6 (2001), 718–729.
17. Asadollahi, M., Ramezani, M., Khanmoradi, Z., Karimialavijeh, E., The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial. Clin. Rehabil. 32:8 (2018), 1069–1075.
18. FOCUS Trial Collaboration, Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet 393:10168 (2019), 265–274.
19. Jin, H.J., Pei, L., Li, Y.N., Zheng, H., et al. Alleviative effects of fluoxetine on depressive-like behaviors by epigenetic regulation of BDNF gene transcription in mouse model of post-stroke depression. Sci. Rep., 7(1), 2017, 14926, 10.1038/s41598-017-13929-5.
20. Sun, X., Zhou, Z., Liu, T., Zhao, M., et al. Fluoxetine enhances neurogenesis in aged rats with cortical infarcts, but this is not reflected in a behavioral recovery. J. Mol. Neurosci. 58:2 (2016), 233–242.
21. Boyeson, M.G., Harmon, R.L., Jones, J.L., Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. Am. J. Phys. Med. Rehabil. 73:2 (1994), 76–83.
22. Hu, M.Z., Wang, A.R., Zhao, Z.Y., Chen, X.Y., et al. Antidepressant-like effects of paeoniflorin on post-stroke depression in a rat model. Neurol. Res. 41:5 (2019), 446–455.
23. Jian, Fang, Xiao-hui, L.I., Wen-wu, Chen, Effect of Shugan Jieyu capsules on serum brain-derived neurotrophic factor and 5-HT levels with post stroke depression patients. Shi Jie Lin Chuang Yao Wu 36:5 (2015), 331–333 +344.
24. Guo, Y., Zhang, N., Sun, W., Duan, X., et al. Bioactive polycyclic polyprenylated acylphloroglucinols from Hypericum perforatum. Org. Biomol. Chem. 16:43 (2018), 8130–8143.
25. Xiao, Z., Ni, X., Gao, J., Chen, H., et al. The efficacy and safety of Shu-Gan-Jie-Yu capsule in the treatment of post-stroke depression. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 13:11 (2015), 1326–1328.
26. Ben-Eliezer, D., Yechiam, E., Hypericum perforatum as a cognitive enhancer in rodents: a meta-analysis. Sci. Rep., 6, 2016, 35700, 10.1038/srep35700.
27. Oliveira, A.I., Pinho, C., Sarmento, B., Dias, A.C., Neuroprotective activity of Hypericum perforatum and its major components. Front. Plant Sci., 7, 2016, 1004, 10.3389/fpls.2016.01004.
28. Tian, J., Zhang, F., Cheng, J., Guo, S., et al. Antidepressant-like activity of adhyperforin, a novel constituent of Hypericum perforatum L. Sci. Rep., 4, 2014, 5632, 10.1038/srep05632.
29. Li, Z., Qin, C., Li, D., Hou, Y., et al. Molecularly imprinted polymer for specific extraction of hypericin from Hypericum perforatum L. herbal extract. J. Pharm. Biomed. Anal. 98 (2014), 210–220.
30. −TrkB signaling. Molecules, 24(1), 2018, E132, 10.3390/molecules24010132.
31. Huang, L., Zhao, H., Huang, B., Zheng, C., et al. Acanthopanax senticosus: review of botany, chemistry and pharmacology. Pharmazie 66:2 (2011), 83–97.
32. Aghajanian, G.K., Influence of drugs on the firing of serotonin- containing neurons in brain. Fed. Proc. 31 (1972), 91–96.
33. Hasbroucq, T., Rihet, P., Blin, O., Possamai, C.A., Serotonin and human information processing: fluvoxamine can improve reaction time performance. Neurosci. Lett. 229 (1997), 204–208.